GI-102 Fast Track Designation by FDA
As the project partner, BLA congratulates GI Innovation on receiving FDA Fast Track Designation for GI-102 in immuno-oncology therapy Gaithersburg,...
Dr. Li to Attend BioJapan 2025 — Let’s Connect!
Submitting an IND application to the US FDA is a significant step in the development of a new drug or...